Latest Headlines

  1. Pandorum Partners With AGC Biologics To Support Clinical Manufacturing Of Exosome-Based Kuragenx, A Treatment Of Ulcerative Corneal Blindness 1/8/2025

    AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a partnership with Pandorum to produce their flagship product Kuragenx—the 'liquid cornea'—a combination biologic.

  2. Novotech Releases Report On Global Parkinson's Disease Clinical Trial Landscape 12/30/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO), announces the release of its report, Parkinson’s Disease: Global Clinical Trial Landscape 2024. This report provides critical insights into the trends, opportunities, and challenges in Parkinson's disease (PD) research, serving as a valuable resource for companies developing treatments for this complex neurodegenerative disorder.

  3. Novotech Named A Fierce CRO Award Winner In The Excellence In Clinical Trial Management And Global Operations Categories 12/30/2024

    Novotech has announced it was named a Fierce CRO Award winner by Fierce Biotech in the Clinical Trial Management and Global Operations categories.

  4. Novotech Publishes Report On The Global COVID-19 Clinical Trial Landscape 12/30/2024

    The global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics, has released an in-depth report "COVID-19: Global Clinical Trial Landscape 2024."

  5. AES Clean Technology Names Former CRB Executive To Drive Western Region Growth 12/20/2024

    AES Clean Technology, a leading provider of high-performance cleanroom facilities, has today announced the appointment of Jeff Rozelle as Senior Vice President of Business Development, West Region.

  6. OpenClinica Named Top Contender In Electronic Data Capture (EDC) Platforms By Everest Group 12/13/2024

    Everest Group, a leading global research and consulting firm, named OpenClinica a Major Contender in its Life Sciences Electronic Data Capture (EDC) Products PEAK Matrix® Assessment for 2024. The inaugural assessment evaluated 20 best-in-class EDCs based on the impact created in the market and the ability to deliver products successfully. OpenClinica differentiates itself from other EDCs with its vision and capability, earning high marks in technology capability, flexibility and ease of deployment, engagement and commercial model, and customer support.

  7. OpenClinica Debuts Secure, Participant-Friendly Mobile App For Direct Health Record Sharing In Clinical Research 12/13/2024

    OpenClinica Share™ simplifies the sharing of real-world and complex medical data for clinical research by participants.

  8. Cellipont Bioservices And Xiogenix Announce Strategic Partnership To Enhance Client Access To Advanced Filling Systems 12/11/2024
  9. OpenClinica Acquires BuildClinical to Accelerate Patient Recruitment 12/10/2024

    OpenClinica today announced its acquisition of BuildClinical, a health technology company that helps researchers and patients find each other faster. BuildClinical uses advanced data-driven strategies to engage and enroll the ideal clinical trial population needed for a given study. Since its founding in 2020, BuildClinical has successfully enrolled more than 50,000 participants in clinical research studies, while simultaneously accelerating enrollment timelines and reducing participant engagement costs.

  10. Germfree Launches Smarthood™: A Groundbreaking, Software-Agnostic IV Workflow Solution Transforming Sterile Compounding 12/9/2024

    Smarthood™ is the first solution to integrate IV workflow software, hardware, and peripherals directly into the hood enhancing best practices, bolstering safety, and streamlining the entire workflow.